John R. Peters

6.3k total citations · 1 hit paper
132 papers, 4.8k citations indexed

About

John R. Peters is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, John R. Peters has authored 132 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in John R. Peters's work include Diabetes Management and Research (20 papers), Chronic Disease Management Strategies (17 papers) and Growth Hormone and Insulin-like Growth Factors (17 papers). John R. Peters is often cited by papers focused on Diabetes Management and Research (20 papers), Chronic Disease Management Strategies (17 papers) and Growth Hormone and Insulin-like Growth Factors (17 papers). John R. Peters collaborates with scholars based in United Kingdom, United States and Canada. John R. Peters's co-authors include Craig J. Currie, Christopher Ll. Morgan, Chris D. Poole, Marc Evans, M. F. Scanlon, Aodán Tynan, Oswaldo L. Bracco, Robert J. Heine, Carlos Diéguez and Fahmy Hanna and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

John R. Peters

130 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

2010 615 citations Craig J. Currie, John R. Peters et al. The Lancet profile →

Peers

Countries citing papers authored by John R. Peters

Since Specialization

Citations

This map shows the geographic impact of John R. Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Peters more than expected).

Fields of papers citing papers by John R. Peters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Peters. The network helps show where John R. Peters may publish in the future.

Co-authorship network of co-authors of John R. Peters

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Peters. A scholar is included among the top collaborators of John R. Peters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Peters. John R. Peters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Author(s) Pharmacovigilance and Risk Management Strategies 2017: Overview of the Generic Drug Program and Surveillance 2018 ·Therapeutic Innovation & Regulatory Science ·(unknown), John R. Peters, (unknown), (unknown), (unknown), (unknown), Edward K. Kim, (unknown)	2
2	Impact of differing glucose‐lowering regimens on the pattern of association between glucose control and survival 2017 ·Diabetes Obesity and Metabolism ·Craig J. Currie, Sarah E. Holden, Sara Jenkins‐Jones, Christopher Ll. Morgan, (unknown), Swapnil Rajpathak, Berhanu Alemayehu, John R. Peters, Samuel S. Engel	5
3	Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region* 2010 ·Diabetic Medicine ·Christopher Ll. Morgan, John R. Peters, Simon Dixon, Craig J. Currie	26
4	Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study breakdown → 2010 ·The Lancet ·Craig J. Currie, John R. Peters, Aodán Tynan, Marc Evans, Robert J. Heine, Oswaldo L. Bracco, (unknown), Chris D. Poole	615
5	Molecular detection of exercise-induced free radicals following ascorbate prophylaxis in type 1 diabetes mellitus: a randomised controlled trial 2008 ·Diabetologia ·Gareth W. Davison, T Ashton, Lindsay George, Ian Young, Jane McEneny, B. Davies, Simon K. Jackson, John R. Peters, Damian M. Bailey	21
6	Community-based lifestyle interventions: changing behaviour and improving health 2007 ·Journal of Public Health ·Lindsay Blank, Mike Grimsley, Elizabeth Goyder, Elizabeth Ellis, John R. Peters	36
7	Physical activity and health: evidence from a study of deprived communities in England 2007 ·Journal of Public Health ·Elizabeth Ellis, Michael Grimsley, Elizabeth Goyder, (unknown), John R. Peters	9
8	Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus 2002 ·Diabetologia ·Alexandra Milsom, Christopher J. Jones, Jonathan Goodfellow, Michael Frenneaux, John R. Peters, Philip E. James	61
9	Estimating the prevalence of diagnosed diabetes in a health district of Wales: the importance of using primary and secondary care sources of ascertainment with adjustment for death and migration 2000 ·Diabetic Medicine ·Christopher Ll. Morgan, Craig J. Currie, N.C.H. Stott, (unknown), Christopher Butler, John R. Peters	33
10	Relative activity and referral patterns for diabetes and non‐diabetes in general practice 2000 ·Diabetic Medicine ·Christopher Ll. Morgan, Craig J. Currie, J. H. Hunt, J. D. Evans, (unknown), N.C.H. Stott, John R. Peters	8
11	Sex and coronary heart disease: the relative probability of dying in hospital. 1997 ·Heart ·Craig J. Currie, John R. Peters	2
12	Hospital Utilization as a Function of Social Deprivation: Diabetes vs Non-Diabetes 1997 ·Diabetic Medicine ·Christopher Ll. Morgan, Craig J. Currie, John R. Peters	9
13	Urinary growth hormone measurements as a marker of renal tubular function in diabetes mellitus 1993 ·Clinica Chimica Acta ·G. A. Turner, Philip A. Coates, Sam Porter, John R. Peters, J S Woodhead	7
14	Tamm Horsfall protein binds to a single class of carbohydrate specific receptors on human neutrophils 1993 ·Kidney International ·David B. Thomas, Malcolm Davies, John R. Peters, J. D. Williams	33
15	Impact of initial treatment on renal function in newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus 1993 ·Diabetologia ·Jiten Vora, J. Dolben, J D Williams, John R. Peters, D. R. Owens	31
16	Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus 1992 ·Kidney International ·Jiten Vora, J. Dolben, John Dean, David M. Thomas, (unknown), David R. Owens, John R. Peters	113
17	Hyperinsulinaemia and microvascular angina ("syndrome X") 1991 ·The Lancet ·Christopher J. Jones, S.J. Hutchison, A.H. Henderson, John Dean, John R. Peters	87
18	Simultaneous determination of glomerular filtration rate and effective renal plasma flow 1991 ·Clinical Physics and Physiological Measurement ·Jiten Vora, (unknown), David R. Owens, John R. Peters	11
19	Growth Hormone and Its Modulation 1988 ·Journal of the Royal College of Physicians of London ·Carlos Diéguez, M. D. Page, John R. Peters, MF Scanlon	6
20	[Insulin resistance and blood glucose replacement rates in liver cirrhosis. Studies with 14C-glucose (author's transl)]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), (unknown), John R. Peters, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact